EcoDrugPlus

Ensembl ID : ENSCHYG00000025458
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSCHYG00000025216
Gene Symbol: -
Cross references: -
273 Possible Orthologues:

Ensembl ID : ENSCHYG00000025085
Gene Symbol: -
Cross references: -
243 Possible Orthologues:

Ensembl ID : ENSCHYG00000024798
Gene Symbol: -
Cross references: -
297 Possible Orthologues:

Ensembl ID : ENSCHYG00000023886
Gene Symbol: -
Cross references: -
85 Possible Orthologues:

Ensembl ID : ENSCHYG00000023883
Gene Symbol: -
Cross references: -
272 Possible Orthologues:

Ensembl ID : ENSCHYG00000023691
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSCHYG00000023687
Gene Symbol: -
Cross references: -
140 Possible Orthologues:

Ensembl ID : ENSCHYG00000023664
Gene Symbol: -
Cross references: -
222 Possible Orthologues:

Ensembl ID : ENSCHYG00000023650
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSCHYG00000023648
Gene Symbol: -
Cross references: -
287 Possible Orthologues:

Ensembl ID : ENSCHYG00000023600
Gene Symbol: -
Cross references: -
379 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).